Allgemeine Homöopathische Zeitung 2005; 250 - 77
DOI: 10.1055/s-2005-868685

Toxopneustes pileolus – proving of the poisonous but edible „flower“ urchin

Toxopneustes pileolus – Prüfung des giftigen, aber essbaren BlumenseeigelsJ Hildebrandt 1
  • 1St. Pölten, Austria

The edible sea urchin Toxopneustes is exceptional because of its small spines but poisonous claws.

The remedy was prepared from a part of the fresh animal taken from the shores of Bohol/Philippines according to the procedure described by Hahnemann and was potentized to C30 and C200. 14 healthy provers between 21 and 49 years of age and one patient provided symptoms. The double-blind proving took place from June 1998 to August 1999.

Characteristic symptoms were stitching pain, burning pain, pressing pain, itching. Local numbness and coldness were found especially in the extremities. The mind picture showed fear and aggression in dreams (knives, rape, crime). Sleep was disturbed. A migraine settled in the right forehead could be cured (in a prover) and a similar migraine, which had turned into supraorbital neuralgia with decreasing visual field, could be brought back and cured in the patient, whilst her antinuclear antibodies dropped to normal. Many symptoms were related to the upper gastro-intestinal tract: to mouth (aphthae), (wisdom)teeth, abdomen, and to appetite/hunger. Others were related to the spine, with pains extending in different directions.

This sea remedy is the first big proving of a member of the family of sea urchins, which was of benefit in quite severe auto-aggressive disease. It should be considered in treatment of migraine, pain extending from the spine, perhaps also in rheumatic diseases, and ailments of the upper gastro-intestinal tract in patients showing the characteristic signs and mind symptoms.

Keywords:

urchin, Toxopneustes, migraine, antinuclear antibodies (ANA), extending pains, auto-aggressive disease.

Schlüsselwörter:

Seeigel, Toxopneustes, Migräne, Antinucleäre Antikörper (ANA), ausstrahlende Schmerzen, autoaggressive Erkrankung.

Korrespondierender Autor: Dr. Jörg Hildebrandt, Feldmühlweg 103, A-3100 St. Pölten, Austria

E-Mail: j.hildebrandt@telering.at